Balyasny Asset Management L.P. trimmed its stake in Eastman Chemical (NYSE:EMN - Free Report) by 97.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,780 shares of the basic materials company's stock after selling 197,685 shares during the period. Balyasny Asset Management L.P.'s holdings in Eastman Chemical were worth $437,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Crews Bank & Trust acquired a new position in shares of Eastman Chemical in the 4th quarter valued at about $27,000. Picton Mahoney Asset Management boosted its holdings in shares of Eastman Chemical by 62.3% during the 4th quarter. Picton Mahoney Asset Management now owns 323 shares of the basic materials company's stock worth $29,000 after buying an additional 124 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of Eastman Chemical by 384.4% during the 4th quarter. Assetmark Inc. now owns 373 shares of the basic materials company's stock worth $34,000 after buying an additional 296 shares in the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new stake in shares of Eastman Chemical during the 4th quarter worth approximately $35,000. Finally, Stonebridge Financial Group LLC bought a new stake in shares of Eastman Chemical in the 4th quarter valued at $37,000. 83.65% of the stock is owned by institutional investors.
Eastman Chemical Stock Down 1.3%
Shares of Eastman Chemical stock traded down $1.06 on Thursday, hitting $80.42. The company had a trading volume of 203,613 shares, compared to its average volume of 1,078,499. Eastman Chemical has a 1 year low of $70.90 and a 1 year high of $114.50. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.78 and a current ratio of 1.51. The stock has a 50 day moving average of $81.07 and a 200-day moving average of $91.55. The stock has a market capitalization of $9.29 billion, a price-to-earnings ratio of 10.49, a P/E/G ratio of 1.22 and a beta of 1.29.
Eastman Chemical (NYSE:EMN - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.02. The business had revenue of $2.29 billion during the quarter, compared to the consensus estimate of $2.35 billion. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%. Eastman Chemical's revenue was down .9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.61 earnings per share. As a group, sell-side analysts forecast that Eastman Chemical will post 8.55 earnings per share for the current year.
Eastman Chemical Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 8th. Stockholders of record on Friday, June 13th will be paid a $0.83 dividend. The ex-dividend date of this dividend is Friday, June 13th. This represents a $3.32 annualized dividend and a dividend yield of 4.13%. Eastman Chemical's payout ratio is 42.24%.
Analyst Ratings Changes
Several brokerages recently issued reports on EMN. Wells Fargo & Company cut their target price on shares of Eastman Chemical from $125.00 to $90.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 9th. The Goldman Sachs Group dropped their price objective on shares of Eastman Chemical from $112.00 to $87.00 and set a "neutral" rating on the stock in a report on Monday, April 28th. Piper Sandler reduced their target price on Eastman Chemical from $105.00 to $99.00 and set a "neutral" rating for the company in a research note on Monday, April 7th. StockNews.com lowered Eastman Chemical from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Finally, Mizuho upgraded Eastman Chemical from a "neutral" rating to an "outperform" rating and set a $105.00 price target on the stock in a report on Thursday, April 3rd. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $99.15.
Read Our Latest Research Report on Eastman Chemical
Eastman Chemical Profile
(
Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Read More

Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.